Eastman Chemical (EMN) Stock Rating Reaffirmed by Royal Bank of Canada

Royal Bank of Canada reissued their hold rating on shares of Eastman Chemical (NYSE:EMN) in a report published on Tuesday. The firm currently has a $103.00 price target on the basic materials company’s stock.

Other equities research analysts also recently issued reports about the stock. ValuEngine downgraded shares of Eastman Chemical from a strong-buy rating to a buy rating in a report on Monday, April 2nd. Jefferies Group reaffirmed a buy rating on shares of Eastman Chemical in a report on Friday, March 9th. Zacks Investment Research raised shares of Eastman Chemical from a hold rating to a buy rating and set a $119.00 price objective on the stock in a report on Wednesday, March 7th. KeyCorp reaffirmed a buy rating and set a $118.00 price objective (up from $108.00) on shares of Eastman Chemical in a report on Monday, January 8th. Finally, Barclays upped their price objective on shares of Eastman Chemical from $100.00 to $108.00 and gave the company an equal weight rating in a report on Monday, February 5th. Eight equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus price target of $103.93.

How to Become a New Pot Stock Millionaire

EMN opened at $108.15 on Tuesday. The stock has a market cap of $15,340.33, a P/E ratio of 14.08, a P/E/G ratio of 1.41 and a beta of 1.21. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.59 and a quick ratio of 0.82. Eastman Chemical has a fifty-two week low of $76.11 and a fifty-two week high of $112.45.

Eastman Chemical (NYSE:EMN) last released its quarterly earnings data on Thursday, February 1st. The basic materials company reported $1.62 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.06 by $0.56. The business had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.24 billion. Eastman Chemical had a net margin of 15.44% and a return on equity of 22.02%. The company’s revenue was up 8.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.51 earnings per share. analysts predict that Eastman Chemical will post 8.54 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, April 6th. Stockholders of record on Thursday, March 15th were issued a $0.56 dividend. This represents a $2.24 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date of this dividend was Wednesday, March 14th. Eastman Chemical’s payout ratio is 29.43%.

In other news, Director Stephen R. Demeritt sold 4,000 shares of the stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $99.84, for a total value of $399,360.00. Following the sale, the director now directly owns 17,732 shares of the company’s stock, valued at $1,770,362.88. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Curtis E. Espeland sold 47,000 shares of the stock in a transaction dated Friday, March 2nd. The stock was sold at an average price of $100.00, for a total transaction of $4,700,000.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 142,935 shares of company stock worth $14,241,099. Insiders own 1.18% of the company’s stock.

Institutional investors have recently made changes to their positions in the company. Steward Partners Investment Advisory LLC purchased a new stake in Eastman Chemical in the third quarter valued at approximately $113,000. Balter Liquid Alternatives LLC purchased a new stake in Eastman Chemical in the fourth quarter valued at approximately $115,000. Advisors Preferred LLC purchased a new stake in Eastman Chemical in the fourth quarter valued at approximately $120,000. NuWave Investment Management LLC purchased a new stake in Eastman Chemical in the fourth quarter valued at approximately $123,000. Finally, Vigilant Capital Management LLC purchased a new stake in Eastman Chemical in the fourth quarter valued at approximately $126,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/18/eastman-chemical-emn-stock-rating-reaffirmed-by-royal-bank-of-canada.html.

Eastman Chemical Company Profile

Eastman Chemical Company manufactures and sells materials, specialty additives, chemicals, and fibers in the United States and internationally. The company's Additives & Functional Products segment offers specialty coalescents, specialty and commodity solvents, paint additives, and specialty polymers; hydrocarbon and rosin resins; insoluble sulfur and antidegradant rubber additives; performance resins and amine derivative-based building blocks; heat transfer and aviation fluids; formic acid-based solutions; and metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators.

Analyst Recommendations for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply